Argent BioPharma Limited (RGT.L)

GBp 6.0

(-7.69%)

Revenue Summary of Argent BioPharma Limited

Argent BioPharma Limited's latest annual revenue in 2023 was 891.08 Thousand AUD , down -49.87% from previous year.
Argent BioPharma Limited's latest quarterly revenue in 2023 Q4 was 320.62 Thousand GBP , down -15.71% from previous quarter.
Argent BioPharma Limited reported a annual revenue of 1.77 Million AUD in annual revenue 2022, down -33.75% from previous year.
Argent BioPharma Limited reported a annual revenue of 2.68 Million AUD in annual revenue 2021, up 64.77% from previous year.
Argent BioPharma Limited reported a quarterly revenue of 380.36 Thousand GBP for 2023 Q2, down -74.65% from previous quarter.
Argent BioPharma Limited reported a quarterly revenue of 1.77 Million AUD for 2022 FY, down -33.75% from previous quarter.

Annual Revenue Chart of Argent BioPharma Limited (2023 - 2015)

Historical Annual Revenue of Argent BioPharma Limited (2023 - 2015)

Year	Revenue	Revenue Growth
2023	891.08 Thousand AUD	-49.87%
2022	1.77 Million AUD	-33.75%
2021	2.68 Million AUD	64.77%
2020	1.62 Million AUD	40.54%
2019	1.15 Million AUD	220.18%
2018	361.84 Thousand GBP	117.84%
2017	166.1 Thousand GBP	133.94%
2016	71 Thousand GBP	5702.23%
2015	1223.74 GBP	0.0%

Year	Revenue	Revenue Growth
2023 Q4	320.62 Thousand GBP	-15.71%
2023 Q2	380.36 Thousand GBP	-74.65%
2022 FY	1.77 Million AUD	-33.75%
2022 Q4	1.5 Million GBP	22.17%
2022 Q2	1.22 Million GBP	-10.84%
2021 Q2	1.2 Million GBP	188.19%
2021 FY	2.68 Million AUD	64.77%
2021 Q4	1.37 Million GBP	14.1%
2020 Q4	418.81 Thousand GBP	149.16%
2020 FY	1.62 Million AUD	40.54%
2020 Q2	168.09 Thousand GBP	-82.18%
2019 FY	1.15 Million AUD	220.18%
2019 Q4	943.19 Thousand GBP	0.0%
2018 FY	361.84 Thousand GBP	117.84%
2017 FY	166.1 Thousand GBP	133.94%
2016 FY	71 Thousand GBP	5702.23%
2015 FY	1223.74 GBP	0.0%

Peer Revenue Comparison of Argent BioPharma Limited

Name	Revenue	Revenue Difference